EGF receptor antagonism inhibits in vivo angiogenesis and produces a survival benefit in pancreatic adenocarcinoma

✍ Scribed by A.J. Durkin; A.S. Rosemurgy; P. Hodul; T.J. Yeatman; D. Cojita; D.W. Shields; E.E. Zervos

• Book ID: 116701487
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 68 KB
• Volume: 121
• Category: Article
• ISSN: 0022-4804
• DOI: 10.1016/j.jss.2004.07.041